Sunday, July 20, 2014

Study of FDA-approved drugs in flies points to possible combined therapies for cancer treatment

Markstein M, Dettorre S, Cho J, Neumüller RA, Craig-Müller S, Perrimon N. Systematic screen of chemotherapeutics in Drosophila stem cell tumors. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4530-5. PMID: 24616500; PMCID: PMC3970492.

From the abstract: "Here we report the development of an in vivo system to study the interaction of stem cells with drugs using a tumor model in the adult Drosophila intestine. ... These results reveal an unanticipated side effect on stem cells that may contribute to tumor recurrence. ... An immediate implication of our findings is that supplementing traditional chemotherapeutics with anti-inflammatories may reduce tumor recurrence."

No comments:

Post a Comment